{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:21:17Z","timestamp":1790187677513,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.tem.2021.04.007","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T09:17:41Z","timestamp":1620724661000},"page":"423-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing the risk of having a child with classic 21-hydroxylase deficiency: a new paradigm"],"prefix":"10.1016","volume":"32","author":[{"given":"Jacob","family":"Ilany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2021.04.007_bb0005","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/humupd\/dmx014","article-title":"Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women","volume":"23","author":"Carmina","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tem.2021.04.007_bb0015","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2021.04.007_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.steroids.2016.01.007","article-title":"21-Hydroxylase deficiancy-induced congenital adrenal hyperplasia in 230 Chinese patients: genotype-phenotype correlation and identification of nine novel mutations","volume":"108","author":"Wang","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.tem.2021.04.007_bb0025","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data","volume":"57","author":"New","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM198807073190104","article-title":"Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1","volume":"319","author":"Speiser","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2021.04.007_bb0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jcem.87.2.8247","article-title":"Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations","volume":"87","author":"Bachega","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0050","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","author":"Bidet","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/cen.12543","article-title":"The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene","volume":"82","author":"Livadas","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2021.04.007_bb0060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2265.2000.00995.x","article-title":"Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"52","author":"Bachega","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2021.04.007_bb0065","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40618-020-01235-3","article-title":"Steroid buomarkers for identifying non-classic adrenal hyperplasis due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone","volume":"43","author":"Oriolo","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.tem.2021.04.007_bb0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1542\/peds.101.4.583","article-title":"Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia","volume":"101","author":"Therrell","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.tem.2021.04.007_bb0075","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2021.04.007_bb0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0035-1565183","article-title":"Fertility and pregnancy in primary adrenal insufficiency in Germany","volume":"48","author":"Remde","year":"2016","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2021.04.007_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12884-018-2091-8","article-title":"Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency","volume":"18","author":"Dorr","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.tem.2021.04.007_bb0090","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1210\/jc.2006-0062","article-title":"Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"91","author":"Moran","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0095","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians","volume":"19","author":"Hannah-Shmouni","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.tem.2021.04.007_bb0100","first-page":"866","article-title":"Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"81","author":"Pang","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.tem.2021.04.007_bb0105","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/mgme.2000.3036","article-title":"A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype","volume":"71","author":"Speiser","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1430397","article-title":"Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency","volume":"143","author":"Weintrob","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2021.04.007_bb0120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2009-1383","article-title":"Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"95","author":"Bidet","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0125","first-page":"960","article-title":"Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia","volume":"84","author":"Fitness","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jc.2004-1728","article-title":"Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population","volume":"90","author":"Baumgartner-Parzer","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0145","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/j.jogc.2017.06.013","article-title":"No. 261-Prenatal screening for fetal aneuploidy in singleton pregnancies","volume":"39","author":"Chitayat","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.tem.2021.04.007_bb0150","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/cen.13429","article-title":"Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome","volume":"87","author":"Eyal","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2021.04.007_bb0155","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fendo.2019.00432","article-title":"The complexities in genotyping of congenital adrenal hyperplasia: 21-hydroxylase deficiency","volume":"10","author":"Pignatelli","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tem.2021.04.007_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humupd\/dmh047","article-title":"Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"10","author":"Forest","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tem.2021.04.007_bb0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.metabol.2017.03.003","article-title":"CYP21A2 intronic variants causing 21-hydroxylase deficiency","volume":"71","author":"Concolino","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2021.04.007_bb0170","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1210\/jc.2006-2163","article-title":"Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency","volume":"92","author":"Araujo","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/humu.23351","article-title":"CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants","volume":"39","author":"Simonetti","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tem.2021.04.007_bb0180","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1210\/clinem\/dgaa875","article-title":"Salt-losing 21-hydroxylase deficiency caused by double homozygosity for two \u201cmild\u201d mutations","volume":"106","author":"Ilany","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12020-015-0731-6","article-title":"Biochemical and genetic diagnosis of 21-hydroxylase deficiency","volume":"50","author":"Falhammar","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2021.04.007_bb0190","first-page":"1505","article-title":"Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency","volume":"84","author":"Nordenstrom","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0195","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-18-0712","article-title":"Management of endocrine disease: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency","volume":"180","author":"Nordenstrom","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2021.04.007_bb0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/jcem-69-3-577","article-title":"21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis","volume":"69","author":"Azziz","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.04.007_bb0205","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study","volume":"72","author":"Azziz","year":"1999","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2021.04.007_bb0210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem-63-2-418","article-title":"Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency","volume":"63","author":"Dewailly","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276021000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276021000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:41:00Z","timestamp":1760906460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276021000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1043276021000795"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2021.04.007","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the risk of having a child with classic 21-hydroxylase deficiency: a new paradigm","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2021.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}